X-Received: by 2002:a37:2f86:0:b0:6af:4c8c:ee8b with SMTP id v128-20020a372f86000000b006af4c8cee8bmr19434237qkh.633.1656933513085;
Mon, 04 Jul 2022 04:18:33 -0700 (PDT)
X-Received: by 2002:a05:622a:1741:b0:31d:4ab9:1661 with SMTP id
l1-20020a05622a174100b0031d4ab91661mr4425973qtk.579.1656933512920; Mon, 04
Jul 2022 04:18:32 -0700 (PDT)
Path: i2pn2.org!i2pn.org!weretis.net!feeder6.news.weretis.net!news.misty.com!border2.nntp.dca1.giganews.com!nntp.giganews.com!news-out.google.com!nntp.google.com!postnews.google.com!google-groups.googlegroups.com!not-for-mail
Newsgroups: comp.arch
Date: Mon, 4 Jul 2022 04:18:32 -0700 (PDT)
Injection-Info: google-groups.googlegroups.com; posting-host=104.223.104.235; posting-account=hkCnjwoAAAD931FDYXyewH5MrRYaKfqN
NNTP-Posting-Host: 104.223.104.235
User-Agent: G2/1.0
MIME-Version: 1.0
Message-ID: <8a9e9666-4c7e-48de-8934-209515cf2760n@googlegroups.com>
Subject: (PDF) Pharmacology and Therapeutics of Asthma and COPD by Clive P. Page
From: hesterho...@gmail.com (Hester Holt)
Injection-Date: Mon, 04 Jul 2022 11:18:33 +0000
Content-Type: text/plain; charset="UTF-8"
Lines: 1